Has Peter Hanna, MD received payments from drug or device companies?

Yes. Drug and device makers reported $23,978 in general payments to Peter Hanna, MD across 89 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter Hanna, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter Hanna, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter Hanna, MD

Cardiovascular Disease · Los Angeles, CANPI 1588906929

Payments from drug & device makers

$23,978in general payments, 2019–2025

Across 89 payments — averaging $269.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$13K
Boston Scientific$8K
Abbott$2K
Biotronik Inc.$885
Bioventus LLC$186
Biosense Webster, Inc.$146
plus $207 from 4 others

What the payments were for

Grants$19,00079%
Travel & lodging$700%
Food & beverage$3,98317%
Education$9244%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	41	$12,538
Boston Scientific	9	$7,841
Abbott	19	$2,175
Biotronik Inc.	11	$885
Bioventus LLC	3	$186
Biosense Webster, Inc.	1	$146
Philips North America LLC	1	$103
Baylis Medical Company Inc	2	$56
Lilly USA, LLC	1	$34
Cook Medical LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EMBLEM MRI S-ICD$7,500
ENSITE PRECISION$585
ENSITE$479
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$446
TACTICATH ABLATION CATHETER, SENSOR ENABLED$179
AURORA EV-ICD MRI SURESCAN$164
Carto 3$146
Exogen Ultrasound Bone Healing System$111
Spartacus$103

How this compares

$23,978 in reported general payments places this provider in the 80th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California →

Medicare billing

Part B allowed, 2024

$31,100

Medicare patients

Services billed

302

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Los Angeles

Kalyanam ShivkumarLos Angeles$2.9M
Priscilla HsueLos Angeles$2.3M
Cathleen Bairey-MerzLos Angeles$1.4M
Somjot BrarLos Angeles$1.2M
Freny ModyLos Angeles$960K
Jamil AboulhosnLos Angeles$683K
Parveen GargLos Angeles$653K
Karol WatsonLos Angeles$553K
Ted LoveHillsborough$102.8M
Matthew BudoffTorrance$11.3M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →